8-Chloro-5,10-dihydro-11H-dibenzo[b,e][1,4]-diazepin-11-one, 95.0%, 250mg

2-(3,4-Dimethylbenzyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 100mg

(S)-(-)-NBD-Pro-COCl [=(S)-(-)-4-Nitro-7-(2-chloroformylpyrrolidin-1-yl)-2,1,3-benzoxadiazole] [HPLC Labeling Reagent for e.e. Determination]>95.0%(HPLC)(qNMR)100mg

D-Phenylalanine amide hydrochloride, 95.0%, 1g

Amido black 10 B (C.I. 20470), 25 g

Methyl 3-(3,5-di-tert-butyl-4-hydroxyphenyl)-propionate, 95.0%, 1kg

2-Chloro-6-fluorobenzo[d]thiazole, 95.0%, 10g

2-(Hydroxymethyl)thiazole-4-carboxylic acid, 95%, 250mg

Multi-channel microliter pipette Pipetman® L 12-channel, 20 to 300 µl, P12x300L, 1 piece

1-Benzyl 2-methyl (2R,4R)-4-((tert-butoxycarbonyl)amino)pyrrolidine-1,2-dicarboxylate, 98%, 1g

(S)-1-(6-(4-Fluoro-1H-pyrazol-1-yl)pyridin-3-yl)ethanamine dihydrochloride, 96%, 1g

3-(4-oxo-1,4-dihydroquinazolin-2-yl)phenyl acetate, 97%, 100mg

4-imino-3-(4-methylphenyl)-1,2,3,4-tetrahydroquinazolin-2-one, 95.0%, 1g